Zions Bancorporation, National Association’s Amicus Therapeutics FOLD Stock Holding History

Zions Bancorporation, National Association’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-144	Closed	-$2.08K	–	1662
2026 Q1	$2.08K	Buy	+144	New	+$2.06K	﹤0.01%	1199

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Zions Bancorporation, National Association's FOLD Position: Q2 2026 in Review

Zions Bancorporation, National Association sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 144 shares — an estimated $2.08K sold.

Zions Bancorporation, National Association first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $2.08K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Zions Bancorporation, National Association reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Zions Bancorporation, National Association sold 144 Amicus Therapeutics shares in Q2 2026, an estimated $2.08K.
Zions Bancorporation, National Association first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Zions Bancorporation, National Association's Amicus Therapeutics position peaked at $2.08K in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.